Possible use of alcohol vapors by inhalation in the treatment of COVID-19 in clinical ill patients


  • Saif ul Islam Adventist Hospital, United States of America




COVID-19, Ethanol vapors, Inhalation


Ethyl alcohol or ethanol is an effective chemical in denaturing enveloped viruses in vitro, including SARS-CoV-2. It is found that exposure of only 30 seconds is sufficient to deactivate the virus. Alcohol has never been used for the treatment of viral lung infection. However, alcohol vapors by inhalation are used for acute respiratory distress syndrome and alcohol withdrawals.


Vincent J, Taccone F. Understanding pathways to death in patients with COVID-19. Lancet Respir Med. 2020;8(5):430-2.

Levison M. Commentary Coronavirus Update, Merck Manual, Professional edition. Available at: https://www.merckmanuals.com/professional/ news/editorial/2020/03/26/17/16/covid19-update-2. Accessed on 1 April 2020.

Centre for disease control and prevention. Available at: WWW.CDC.gov/coronavirus 2019-ncov/hcp/therapeutic-option. Accessed on 1 April 2020.

Kempf G. Efficacy of ethanol against viruses in hand disinfection. Journal of Hospital Infection. 2018;98(4)331-8.

Aldo A. Treatment of pulmonary edema. JAMA. 1954;1(154):62.

Zheng P, Yang Z, Zhao Y, Liu Y, Zhang L, Shao G, et al. Inhalation of alcohol vapor driven by oxygen is a useful therapeutic method for postoperative alcohol withdrawal syndrome in a patient with esophageal cancer: a case report. Alcohol and Alcoholism. 2011;46(4):424-6.

Kong F, Zhang M, Wang H, Liu D, Wu Y, Chai N, et al. Symptom-triggered alcohol vapor inhalation for postoperative alcohol withdrawal syndrome in patients with gastroesophageal carcinoma. JBUON. 2017;22(5):1266-71.

Alcohol Inhalation. Available at: https://en. wikipedia.org/wiki/Alcohol_inhalatio. Accessed on 1 April 2020.

Kaphalia L, Calhoun WJ. Alcoholic lung injury: metabolic, biochemical and immunological aspects. Toxicol Lett. 2013;222(2):171-9.




How to Cite

Islam, S. ul. (2020). Possible use of alcohol vapors by inhalation in the treatment of COVID-19 in clinical ill patients. International Journal of Basic & Clinical Pharmacology, 9(10), 1627–1628. https://doi.org/10.18203/2319-2003.ijbcp20204099